ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE) — FDA Approval ANDA210708 (AUROBINDO PHARMA)
ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE) — FDA Approval ANDA210708 (AUROBINDO PHARMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ELETRIPTAN HYDROBROMIDE; Active ingredients: ELETRIPTAN HYDROBROMIDE; Application number: ANDA210708.
| Brand name | ELETRIPTAN HYDROBROMIDE |
|---|---|
| Active ingredients | ELETRIPTAN HYDROBROMIDE |
| Application number | ANDA210708 |
| Sponsor | AUROBINDO PHARMA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20190115 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →